Crossmark

Random non-fasting C-peptide testing can identify patients with insulin-treated type 2 diabetes at high risk of hypoglycaemia

Crossref DOI link: https://doi.org/10.1007/s00125-017-4449-2

Published Online: 2017-10-05

Published Print: 2018-01

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Hope, Suzy V.

Knight, Bridget A.

Shields, Beverley M.

Hill, Anita V.

Choudhary, Pratik

Strain, W. David

McDonald, Timothy J.

Jones, Angus G.
Funding

Funding for this research was provided by:

Northcott Devon Foundation

National Institute for Health Research
License Information

License valid from 2017-10-05